Jun Takayama

1.7k total citations
41 papers, 1.2k citations indexed

About

Jun Takayama is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Jun Takayama has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 10 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in Jun Takayama's work include Oxidative Organic Chemistry Reactions (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (7 papers). Jun Takayama is often cited by papers focused on Oxidative Organic Chemistry Reactions (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (7 papers). Jun Takayama collaborates with scholars based in Japan, United States and Slovakia. Jun Takayama's co-authors include Arun K. Ghosh, Andrew D. Mesecar, Kiira Ratia, Susan C. Baker, Rima Chaudhuri, Michael E. Johnson, Surendranath Baliji, Bellur S. Prabhakar, Katrina Sleeman and Melissa M. Coughlin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Virology.

In The Last Decade

Jun Takayama

38 papers receiving 1.2k citations

Peers

Countries citing papers authored by Jun Takayama

Since Specialization

Citations

This map shows the geographic impact of Jun Takayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Takayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Takayama more than expected).

Fields of papers citing papers by Jun Takayama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Takayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Takayama. The network helps show where Jun Takayama may publish in the future.

Co-authorship network of co-authors of Jun Takayama

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Takayama. A scholar is included among the top collaborators of Jun Takayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Takayama. Jun Takayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FAD012, a Ferulic Acid Derivative, Preserves Cerebral Blood Flow and Blood–Brain Barrier Integrity in the Rat Photothrombotic Stroke Model 2025 ·Biomedicines ·(unknown), Hirokazu Matsuzaki, Jun Takayama, Naohiro Iwata, (unknown), Bo Yuan, Takeshi Sakamoto, Mari Okazaki	0
2	CUD003, a Novel Curcumin Derivative, Ameliorates LPS-Induced Impairment of Endothelium-Dependent Relaxation and Vascular Inflammation in Mice 2025 ·International Journal of Molecular Sciences ·Hirokazu Matsuzaki, (unknown), (unknown), Bo Yuan, Jun Takayama, Takeshi Sakamoto, Mari Okazaki	1
3	Chronic Administration with FAD012 (3,5-Dimethyl-4-hydroxycinnamic Acid) Maintains Cerebral Blood Flow and Ameliorates Swallowing Dysfunction After Chronic Cerebral Hypoperfusion in Rats 2025 ·International Journal of Molecular Sciences ·Takashi Asano, Hirokazu Matsuzaki, (unknown), Bo Yuan, Jun Takayama, Takeshi Sakamoto, Mari Okazaki	2
4	Involvement of the Restoration of Cerebral Blood Flow and Maintenance of eNOS Expression in the Prophylactic Protective Effect of the Novel Ferulic Acid Derivative FAD012 against Ischemia/Reperfusion Injuries in Rats 2023 ·International Journal of Molecular Sciences ·Takashi Asano, (unknown), Naohiro Iwata, Jun Takayama, (unknown), (unknown), (unknown), (unknown), Hirokazu Matsuzaki, Bo Yuan, Shinya Kamiuchi, Yasuhide Hibino, Takeshi Sakamoto, Mari Okazaki	9
5	Machine Learning Study of Antioxidant Effects with Molecular Orbital Energies as Explanatory Variables 2022 ·Journal of Computer Chemistry Japan ·Hiroyuki Teramae, (unknown), Jun Takayama, Mari Okazaki, Takeshi Sakamoto	0
6	A study of enantioselective syntheses by Sharpless asymmetric oxidation for aryl sulfoxides containing oxygen groups at the ortho position 2021 ·Journal of Chemical Sciences ·(unknown), Jun Takayama, (unknown), (unknown), Hiroshi Miyamae, Takeshi Sakamoto	0
7	Improvement of the Solubility and Evaluation of the Physical Properties of an Inclusion Complex Formed by a New Ferulic Acid Derivative and γ-Cyclodextrin 2020 ·ACS Omega ·(unknown), Yutaka Inoue, Yuka Ogata, Isamu Murata, (unknown), Jun Takayama, Takeshi Sakamoto, Mari Okazaki, Ikuo Kanamoto	19
8	Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design, synthesis, and biological evaluation 2019 ·Bioorganic & Medicinal Chemistry Letters ·Arun K. Ghosh, (unknown), (unknown), Jun Takayama, (unknown), D. Eric Walters, Shin‐ichiro Hattori, Manabu Aoki, Hiroaki Mitsuya	8
9	Characterization of 6‐bromoferulic acid as a novel common‐use matrix for matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry 2019 ·Rapid Communications in Mass Spectrometry ·(unknown), (unknown), Takeshi Sakamoto, Takeshi Moriguchi, Jun Takayama, (unknown), Mari Okazaki, Yuko Suzuki, (unknown), Yasushi Sakamoto	1
10	Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex 2017 ·Bioorganic & Medicinal Chemistry ·Arun K. Ghosh, Margherita Brindisi, Prasanth R. Nyalapatla, Jun Takayama, (unknown), (unknown), Johnson Agniswamy, Yuan-Fang Wang, Manabu Aoki, Masayuki Amano, Irene T. Weber, Hiroaki Mitsuya	14
11	A fission yeast cell-based system for multidrug resistant HIV-1 proteases 2017 ·Cell & Bioscience ·Zsigmond Benkő, Dong Liang, Ge Li, Robert T. Elder, Anindya Sarkar, Jun Takayama, Arun K. Ghosh, Yuqi Zhao	8
12	Systematic evaluation of methyl ester bioisosteres in the context of developing alkenyldiarylmethanes (ADAMs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) for anti-HIV-1 chemotherapy 2016 ·Bioorganic & Medicinal Chemistry ·(unknown), Takeshi Sakamoto, Jun Takayama, (unknown), Mari Okazaki, Tracy L. Hartman, Robert W. Buckheit, Christophe Pannecouque, Mark Cushman	7
13	Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands 2015 ·Bioorganic & Medicinal Chemistry Letters ·Arun K. Ghosh, Jun Takayama, (unknown), (unknown), (unknown), Johnson Agniswamy, Yuan-Fang Wang, Manabu Aoki, Masayuki Amano, Irene T. Weber, Hiroaki Mitsuya	32
14	Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease 2009 ·Journal of Medicinal Chemistry ·Arun K. Ghosh, Jun Takayama, (unknown), Kiira Ratia, Rima Chaudhuri, (unknown), Katrina Sleeman, Melissa M. Coughlin, Daniel Brian Nichols, Debbie C. Mulhearn, Bellur S. Prabhakar, Susan C. Baker, Michael E. Johnson, Andrew D. Mesecar	109
15	A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication 2008 ·Proceedings of the National Academy of Sciences ·Kiira Ratia, Scott D. Pegan, Jun Takayama, Katrina Sleeman, Melissa M. Coughlin, Surendranath Baliji, Rima Chaudhuri, Wentao Fu, Bellur S. Prabhakar, Michael E. Johnson, Susan C. Baker, Arun K. Ghosh, Andrew D. Mesecar	366
16	Enantioselective synthesis of cyclopentyltetrahydrofuran (Cp-THF), an important high-affinity P2-ligand for HIV-1 protease inhibitors 2008 ·Tetrahedron Letters ·Arun K. Ghosh, Jun Takayama	10
17	Potent HIV-1 protease inhibitors incorporating meso-bicyclic urethanes as P2-ligands: structure-based design, synthesis, biological evaluation and protein–ligand X-ray studies 2008 ·Organic & Biomolecular Chemistry ·Arun K. Ghosh, Sandra Gemma, Jun Takayama, Abigail Baldridge, (unknown), Heather B. Miller, Yuan-Fang Wang, Andrey Kovalevsky, (unknown), Irene T. Weber, Hiroaki Mitsuya	15
18	π-Face-Selective Diels−Alder Reactions of 3,4-Di-tert-butylthiophene 1-Oxide and 1-Imide and Formation of 1,2-Thiazetidines 2003 ·Journal of the American Chemical Society ·Takashi Otani, Jun Takayama, Yoshiaki Sugihara, Akihiko Ishii, Juzo Nakayama	22
19	OLFACTORY NEUROBLASTOMA AS A SECOND MALIGNANT NEOPLASM IN A PATIENT PREVIOUSLY TREATED FOR CHILDHOOD ACUTE LEUKEMIA 2001 ·Pediatric Hematology and Oncology ·(unknown), (unknown), Hiroshi Matsubara, Jun Takayama, (unknown)	6
20	[Tumor markers--personal experience. A case of advanced extragonadal germ-cell tumor showing complete remission by high-dose combination chemotherapy with autologous bone marrow transplantation]. 1991 ·PubMed ·H Ohkura, (unknown), Mayumi Hayashi, Kensei Tobinai, Jun Takayama, Masahiro Ohira, Ken‐ichi Tobisu, Tomoyuki Goya, Hiroaki Kondo, Manabu Shimoyama	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact